(Q56986750)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

0 references

Thomas Kurt Eigentler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Henning Zelba

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Graham Pawelec

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Claus Garbe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Benjamin Weide

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Evelyna Derhovanessian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Annette Pflugfelder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Peter Radny

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Claudia Pföhler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

4139-4146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

Management of cutaneous melanoma

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

The role of surgery in treatment of stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

Adoptive-cell-transfer therapy for the treatment of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

7 January 2021

Intralesional interferon-alpha therapy in advanced malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

7 January 2021

Intralesional interferon treatment of lentigo maligna

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

7 January 2021

Regression of in-transit melanoma of the scalp with intralesional recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

7 January 2021

Peritumoral injections of interleukin 2 induce tumour regression in metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

7 January 2021

Local interleukin 2 therapy is most effective against cancer when injected intratumourally

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

7 January 2021

Intratumoral low-dose interleukin-2 induces rejection of distant solid tumour

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

7 January 2021

In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25156

7 January 2021

Identifiers

DOI

10.1002/CNCR.25156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564107%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference